Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma
Condition(s):Bladder Urothelial CarcinomaLast Updated:December 9, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Bladder Urothelial CarcinomaLast Updated:December 9, 2022Recruiting
Condition(s):Urothelial CarcinomaLast Updated:March 1, 2024Active, not recruiting
Condition(s):Urothelial Carcinoma; Bladder CancerLast Updated:July 20, 2023Recruiting
Condition(s):Metastatic Urothelial Carcinoma; Bladder CancerLast Updated:March 21, 2024Recruiting
Condition(s):Transitional Cell Carcinoma of Urinary TractLast Updated:December 30, 2014Completed
Condition(s):Bladder Transitional Cell Carcinoma Stage IVLast Updated:December 8, 2015Completed
Condition(s):Locally Advanced or Metastatic Urothelial CarcinomaLast Updated:September 29, 2020Not yet recruiting
Condition(s):Bladder Urothelial CarcinomaLast Updated:September 30, 2020Unknown status
Condition(s):Urothelial CarcinomaLast Updated:February 7, 2024Active, not recruiting
Condition(s):Upper Tract Urothelial CarcinomaLast Updated:October 16, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.